Tubal patency after clinical treatment of unruptured ectopic pregnancy

Nenhuma Miniatura disponível
Data
2005-03-01
Autores
Elito, J.
Han, K. K.
Camano, L.
Orientadores
Tipo
Artigo
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Objective: To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy. Method: of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 to February 2002, 30 were treated with a single 50 mg/m(2) dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly. Results: Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. in addition, contralateral tubal. patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups. Conclusion: Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Descrição
Citação
International Journal of Gynecology & Obstetrics. Clare: Elsevier Sci Ireland Ltd, v. 88, n. 3, p. 309-313, 2005.